查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1251521

兒科疫苗市場，按疫苗類型、技術、類型、分銷渠道、地區 - 規模、份額、展望、機會分析，2023-2030 年

Pediatric Vaccines Market, By Vaccine Type, By Technology, By Type, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

疫苗接種是公共醫療保健計劃之一，可在十年內預防數千人死亡、數百萬人患病並節省數十億美元。 免疫接種是保護兒童免受疾病、殘疾和死亡（包括癌症）侵害的安全有效方法。 在大流行和其他突發公共衛生事件期間，保持定期接種疫苗以防止進一步爆發非常重要。 疫苗根據年齡段分為成人疫苗和兒童疫苗。 小兒疫苗是在出生時第一次接種。 然後在出生後 6 週，第 3 劑在出生後 10 週，最後一劑在出生後 14 週。 這種疫苗可預防脊髓灰質炎病毒，這是一種影響神經系統並可能導致完全癱瘓的高度傳染性疾病。

市場動態

疫苗監管審批的增加預計將在預測期內推動市場增長。 例如，2022 年 6 月 18 日，美國疾病控制與預防中心 (CDC) 批准 6 個月及以上的嬰兒接種 COVID-19。 這意味著美國又有 2000 萬五歲以下兒童接種了疫苗。 對於 5 歲以下的兒童，有兩種疫苗可供選擇。 為 6 個月至 4 歲的兒童提供 3 劑輝瑞 COVID-19 疫苗，劑量為 3 微克。 建議 6 個月至 5 歲兒童接種 2 劑 Moderna COVID-19 疫苗，劑量為 25 微克。

市場參與者正專注於增加研發活動，以生產採用各種技術對抗 COVID-19 等傳染病的疫苗。 例如，2022 年 6 月，跨國製藥和生物技術公司輝瑞日本公司和生物技術公司 BioNTech SE 將評估兩種 COVID-19 候選疫苗的安全性、免疫原性和耐受性，單價和二價。 COVID-19 疫苗和候選疫苗的組合針對相關 Omicron BA.1 突變體的刺突蛋白。 2/3 期試驗數據顯示，與公司目前的 COVID-19 疫苗相比，兩種候選疫苗的 Omicron 適應性加強劑量顯著增強了對 Omicron BA.1 的免疫反應。 這種強大的免疫反應在 30mcg 和 60mcg 的兩個研究劑量水平得到證實。 基於 BioNTech 的專有 mRNA 技術，輝瑞 BioNTech COVID-19疫苗由 BioNTech 和輝瑞公司共同開發。

這項研究的主要特點

  • 本報告對全球兒科疫苗市場進行了深入分析，提供了以 2022 年為基準年的預測期 (2023-2030) 的市場規模和復合年增長率 (CAGR%)。我在這裡.
  • 它揭示了各個細分市場的潛在收入機會，並描述了該市場具有吸引力的投資建議矩陣。
  • 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
  • 根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數，對全球兒科疫苗市場主要參與者的概況進行分析。
  • 參與本研究的主要公司包括 GlaxoSmithKline Plc.、Merck & Co., Inc.、Pfizer Inc.、Sanofi S.A.、Panacea Biotec、Zydus Cadila、Emergent BioSolutions Inc.、Serum Institute of India Pvt Ltd.、Bharat Biotech 和 Indian Immunologicals Ltd.。
  • 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 《全球兒科疫苗市場報告》面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球兒科疫苗市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第二章市場範圍

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 市場概況：按疫苗類型分類
    • 市場概況：按技術分類
    • 市場概況：按類型分類
    • 市場概況：按分銷渠道
    • 市場概況：按地區
  • 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

  • 市場動態
    • 司機
    • 約束因素
    • 市場吸引力分析
    • 市場機會
  • 產品發布
  • 合併/收購/合作
  • 監管準則和合規性
  • 主要發展
  • 害蟲分析
  • 技術/情況
  • 對 PORTER 的分析
  • 價格分析 (2021)

第 4 章全球兒科疫苗市場——冠狀病毒 (COVID-19) 大流行的影響

  • 經濟影響
  • COVID-19 流行病學
  • 對供需的影響

第 5 章全球兒科疫苗市場，按疫苗類型分列，2017-2030

  • 肺炎球菌疫苗
  • 百白破疫苗
  • 輪狀病毒疫苗
  • MMR 疫苗
  • 脊髓灰質炎疫苗
  • 流感疫苗
  • 乙型肝炎疫苗
  • 腦膜炎球菌疫苗
  • 乙肝疫苗
  • 水痘（水痘）疫苗

第 6 章全球兒科疫苗市場，按技術分類，2017-2030

  • 活疫苗或減毒疫苗
  • 滅活□□或滅活疫苗
  • 類毒素疫苗
  • 結合疫苗
  • 亞單位疫苗
  • 重組疫苗

第 7 章全球兒科疫苗市場，按類型，2017-2030

  • 單價疫苗
  • 多價疫苗

第 8 章全球兒科疫苗市場，按分銷渠道，2017-2030

  • 政府
  • 私人

第 9 章全球兒科疫苗市場，按地區劃分，2017-2030

  • 北美
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地區
  • 歐洲
  • 英國
  • 德國
  • 意大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東盟
  • 澳大利亞
  • 韓國
  • 其他亞太地區
  • 中東
  • 海灣合作委員會
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中非
  • 南非

第10章競爭格局

  • GlaxoSmithKline Plc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Panacea Biotec
  • Zydus Cadila
  • Emergent BioSolutions Inc.
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech
  • Indian Immunologicals Ltd.

第 11 章章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI1708

Immunizations is one of the public healthcare program for vaccination that prevents thousands of deaths, millions of cases of disease, and saves billions of dollars per decade. Immunizations are a safe, and effective way to protect children from disease including cancers, disability, and death. It is important during a pandemic or other public health emergency to maintain routine immunizations in order to prevent further outbreaks. There are various types of vaccines based on age group that include adult vaccines and pediatric vaccines. The pediatric vaccine is the first dose that is taken at birth. The next dose is taken when the child is 6 weeks old, the third dose at 10 weeks old, and the last dose at 14 weeks old. This vaccine protects against the poliovirus that is a highly infectious disease that invades the nervous system, and can lead to total paralysis.

Market Dynamics

Increasing approval of vaccines by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on June 18, 2022, the Centers for Disease Control and Prevention (CDC) has approved COVID-19 vaccination for young children of age least 6 months old that means 20 million children, in the U.S., that are under 5 years are newly eligible for vaccination. For children under 5, there are two vaccines available. The three-dose Pfizer COVID-19 vaccine is provided to children 6 months to 4 years of age at a 3 microgram dosage. The two-dose Moderna COVID-19 vaccine is recommended for children of age 6 months to 5 years at a dose of 25 micrograms.

Key market players are focusing on increasing research and development activities for producing vaccines that employs various technologies to combat infections such as COVID-19 and others. For instance, in June 2022, Pfizer Inc., a multinational pharmaceutical and biotechnology, and BioNTech SE, a biotechnology company, announced positive data evaluating the safety, immunogenicity, and tolerability, of two Omicron-adapted COVID-19 vaccine candidates: one monovalent and the other bivalent. A combination of the Pfizer-BioNTech COVID-19 Vaccine and a vaccine candidate targets the spike protein of the Omicron BA.1 variant of concern. Data from the Phase 2/3 trial showed that a booster dose of both Omicron-adapted vaccine candidates has substantially higher immune response against Omicron BA.1, as compared to the companies' current COVID-19 vaccine. The robust immune response was seen in two investigational dose levels, 30 µg and 60 µg. The Pfizer-BioNTech COVID-19 Vaccine that is based on BioNTech's proprietary mRNA technology was developed by both BioNTech and Pfizer Inc.

Key features of the study:

  • This report provides in-depth analysis of the global pediatric vaccines market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Pediatric Vaccines Market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Panacea Biotec, Zydus Cadila, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, and Indian Immunologicals Ltd.
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global pediatric vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric vaccines market

Detailed Segmentation:

  • Global Pediatric Vaccines Market, By Vaccine Type:
    • Pneumococcal Vaccine
    • DTP Vaccine
    • Rotavirus Vaccine
    • MMR Vaccine
    • Polio Vaccine
    • Influenza Vaccine
    • Hepatitis B Vaccine
    • Meningococcal Vaccine
    • Hib Vaccine
    • Varicella Vaccine
  • Global Pediatric Vaccines Market, By Technology :
    • Live or Attenuated Vaccine
    • Inactivated or Killed Vaccine
    • Toxoid Vaccine
    • Conjugate Vaccine
    • Subunit Vaccine
    • Recombinant Vaccine
  • Global Pediatric Vaccines Market By Type:
    • Monovalent Vaccine
    • Multivalent Vaccine
  • Global Pediatric Vaccines Market By Distribution Channel:
    • Government
    • Private
  • Global Pediatric Vaccines Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Type:
    • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • GlaxoSmithKline Plc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Sanofi S.A.
    • Panacea Biotec
    • Zydus Cadila
    • Emergent BioSolutions Inc.
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Indian Immunologicals Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Vaccine Type
    • Market Snapshot, By Technology
    • Market Snapshot, By Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Merger, Acquisition, and Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • PORTER's Analysis
  • Pricing Analysis (2021)

4. Global Pediatric Vaccines Market- Impact of Coronavirus (Covid-19) Pandemic

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Pediatric Vaccines Market, By Vaccine Type, 2017-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Pneumococcal Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • DTP Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Rotavirus Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • MMR Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Polio Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Influenza Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Hepatitis B Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Meningococcal Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Hib Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Varicella Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Pediatric Vaccines Market, By Technology, 2017-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Live or Attenuated Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Inactivated or Killed Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Toxoid Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Conjugate Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Subunit Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Recombinant Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Pediatric Vaccines Market, By Type, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Monovalent Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Multivalent Vaccine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Pediatric Vaccines Market, By Distribution Channel, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segments Trends
  • Government
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Pediatric Vaccines Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • GlaxoSmithKline Plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Panacea Biotec
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zydus Cadila
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emergent BioSolutions Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Serum Institute of India Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bharat Biotech
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Indian Immunologicals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

11. Section

  • Research Methodology
  • About Us